Lymphoma Cancer | Tumor

From Chemotherapy to Constituents: Maryland Governor Faces Cancer, Politics

November 10th 2020

Doctors told Maryland Governor Larry Hogan to go home and rest after undergoing cancer surgery. But he had other plans: sharing his health issues.

Educated Patient® Leukemia and Lymphoma Summit: October 27, 2020

October 27th 2020

View the entire CURE® Educated Patient® Leukemia & Lymphoma Summit. A virtual event seeking to educate, inform and challenge the thinking of patients with leukemia and lymphoma.

Friday Frontline: Jeff Bridges Receives a Lymphoma Diagnosis; Controversial Radio Host Rush Limbaugh Announces His Lung Cancer Has Progressed; And More

October 23rd 2020

From acclaimed actor Jeff Bridges tweeting about a new lymphoma diagnosis to controversial conservative radio host Rush Limbaugh announcing that his stage 4 lung cancer has progressed, here’s what’s happening in the cancer landscape this week.

FDA Approves Keytruda for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma

October 15th 2020

Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.

What the FDA’s New Breast Implant Recommendations Mean for Patients

September 30th 2020

In an interview with CURE®, the president of the National Center for Health Research elaborates on the effort to protect patients from potentially serious side effects associated with getting breast implants, including breast implant-associated anaplastic large cell lymphoma.

FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects

September 29th 2020

New guidance from the Food and Drug Administration recommends that the makers of breast implants include a black-box warning, a patient decision checklist and other information on product labels that will help protect them against a cancer and an autoimmune condition that can arise from use of the devices.

New Therapies for Adults and Children With Blood Cancers Hold Promise

September 25th 2020

In this special hematology focused issue of CURE® we look at all the promising treatments and research for both adults and children with blood cancers.

The Price of Hope: Weighing the Cost of CAR-T Cell Therapy in Treating Blood Cancers

September 23rd 2020

Weighing the cost of CAR-T cell therapy in treating blood cancers is a finical burden for many patients with blood cancer.

CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day

September 10th 2020

Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.

5 Reports on Lymphoma Patients May Have Missed

August 31st 2020

CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.

FDA Provides Updated Analysis of Breast Implant-Associated Lymphoma, Breast Implant Illness

August 21st 2020

The FDA also released a video for patients that details seven things they should know about breast implants, including information about breast implant-associated lymphoma and systemic symptoms.

The Future of Follicular Lymphoma Management

August 14th 2020

Managing Quality of Life in R/R Follicular Lymphoma

August 14th 2020

Novel Agents for R/R Follicular Lymphoma Management

August 14th 2020

Progression in R/R Follicular B-Cell Non-Hodgkin Lymphoma

August 14th 2020

Follicular Lymphoma Risk Factors, Diagnosis, Prognosis

August 14th 2020

Muscle Mass and Density Could Factor Into Treatment Decisions and Survival for Some Patients with Lymphoma

August 14th 2020

In patients with diffuse large B-cell lymphoma, low muscle mass (LMM) and low muscle density (LMD) could play a role when deciding what kind of treatment option to pursue, and could also impact a patient’s odds of survival, according to a recent study.

Novel CAR T-Cell Therapy Shows Promise in Advanced Hodgkin Lymphoma

August 14th 2020

“Unlike other CAR T-cell therapies, clinical success was not associated with significant complications from therapy,” said Dr. Jonathan Serody. “This means this treatment should be available to patients in a clinic setting and would not require patients to be hospitalized, which is critical in our current environment.”

How Governor Larry Hogan Leaned on Family After a Cancer Diagnosis

August 13th 2020

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

Governor Larry Hogan 'Still Standing' After Cancer

July 30th 2020

In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.

Ways That People Affected by Cancer Can Earn Money

July 24th 2020

Here, a survivor lists some alternative ways that patients with cancer or survivors in need of flexible employment can earn extra money.

From 'Survivor: Africa' to Surviving Cancer, Ethan Zohn Discusses His Winner's Mentality

July 18th 2020

Ethan Zohn, "Survivor: Africa" winner, discusses how his winner’s mentality helped him through treatment and how leaning on others has been key in survivorship.

Friday Frontline: Cancer Updates, Research and Education on July 10, 2020

July 10th 2020

From a new trial in Canada looking at therapeutics to help prevent severe symptoms of COVID-19 in patients with cancer to updated guidelines from the American Cancer Society on taking the HPV vaccine to prevent certain cancers, here’s what’s making the headlines in the cancer space this week.

Lymphoma Survivor Ethan Zohn Offers Advice to Those Recently Diagnosed With Cancer

June 26th 2020

“Let's try to make something good out of something really bad,” says “Survivor: Africa” winner, and lymphoma survivor, Ethan Zohn.

5 Most Recent FDA Approvals Patients With Cancer May Have Missed

June 23rd 2020

The Food and Drug Administration has had a busy couple of weeks, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

FDA Approves Xpovio For Patients with Relapsed or Refractory DLBCL

June 22nd 2020

The Food and Drug Administration granted accelerated approval to Xpovio for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone two prior therapies.

Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma

June 18th 2020

Dr. Caron A. Jacobson discusses the potential long-term impact of Yescarta for patients with relapsed or refractory indolent non-Hodgkin lymphoma and how it could turn an incurable disease into something curable.

Ethan Zohn: Cancer Treatment is "A Marathon, Not a Sprint"

June 17th 2020

“Survivor: Africa” winner Ethan Zohn details his journey with cancer and discovering that it isn’t a sprint, but a marathon.

Expert Discusses Side Effects of Keytruda That Patients with Hodgkin Lymphoma Should Know About

June 15th 2020

Data presented at the ASCO 2020 Virtual Scientific Program demonstrated that Keytruda was an effective treatment for patients with Hodgkin Lymphoma and side effects were tolerable.

Facing the Challenges of Young Adult Cancer By Finding a Community

June 14th 2020

Being a young adult with cancer can feel like an isolating journey, but "Survivor: Africa" winner Ethan Zohn details how a community can form even in the unlikeliest of places.